Innovation1 Biotech
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$5,988,266 over the previous period. Total operating expenses were $1,367,386.
Profit Margin
| 2015 | 0 | -14.52K | |
|---|---|---|---|
| 2016 | 0 | -35.00K | |
| 2017 | 0 | -35.85K | |
| 2018 | 16.77K | -303.02K | -1806.86% |
| 2019 | 79.24K | -147.37K | -185.97% |
| 2020 | 1.18K | -3.05M | -258778.92% |
| 2021 | 3.08K | 811.56K | 26349.35% |
| 2022 | 0 | -40.87M | |
| 2023 | 0 | -5.98M |
IVBT Income Statement (2015 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|
Revenue | |||||||||
Revenue | 0 | 0 | 3.08K | 1.18K | 79.24K | 16.77K | 0 | 0 | 0 |
Cost of revenue | 52.69K | 2.54M | 1.42K | 2.96K | 129.33K | 81.02K | 0 | 0 | 0 |
Gross profit | -52.69K | -2.54M | 1.65K | -1.78K | -50.09K | -64.25K | 0 | 0 | 0 |
Operating exp. | |||||||||
Research and development | 15K | 201.16K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Selling and marketing | 10.26K | 4.91K | 677 | 2.66K | 94.44K | 61.81K | 14.17K | 0 | 0 |
Total operating expenses | 1.36M | 5.24M | 240.65K | 215.09K | 616.77K | 371.86K | 35.85K | 35.00K | 14.52K |
Operating income | -1.36M | -41.02M | -238.99K | -216.87K | -667.98K | -436.11K | -35.85K | -35.00K | -14.52K |
Other income (expenses), net | -4.62M | -35.63M | 1.27M | -2.36M | 497.92K | -539.40K | 0 | 0 | 0 |
Income before tax | -5.98M | -40.87M | 1.03M | -2.58M | -170.06K | -975.52K | -35.85K | -35.00K | -14.52K |
Income tax expense | 0 | 2.41M | 228.37K | 476.11K | -22.69K | -672.49K | -161.70K | 0 | 0 |
Net income | -5.98M | -40.87M | 811.56K | -3.05M | -147.37K | -303.02K | -35.85K | -35.00K | -14.52K |
Earnings per share | |||||||||
Basic EPS | -0.7 | -2.68 | 4.31 | -10.18 | -0.34 | -0.75 | -0.2 | -0.2 | -0.08 |
Diluted EPS | -0.7 | -2.68 | 4.31 | -10.18 | -0.34 | -0.75 | -0.2 | -0.2 | -0.08 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |